Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
47378
CAS Number:
97322-87-7
Troglitazone
Purity:
≥ 98 % (HPLC)
Synonym(s):
(+/-)-5-[4-[(6-hydroxy-2,5,7,8-tétraméthylchroman-2-yl)méthoxy]benzyl]-2,4-thiazolidinedione
Documents
$208.80 /10 mg
Taille
Request Bulk Quote
Informations sur le produit

Troglitazone is a thiazolidinedione compound primarily recognized for its role in the management of type 2 diabetes. This compound functions as a selective agonist for peroxisome proliferator-activated receptor gamma (PPAR-γ), which plays a crucial role in glucose and lipid metabolism. Troglitazone has been utilized in clinical settings to improve insulin sensitivity, thereby aiding in the regulation of blood sugar levels. Its unique structure allows it to enhance the body's response to insulin, making it a valuable tool in diabetes treatment protocols.

In addition to its antidiabetic properties, Troglitazone has shown potential in research related to cardiovascular health and metabolic syndrome, providing insights into its broader applications in managing chronic conditions. Researchers and healthcare professionals appreciate Troglitazone for its ability to address multiple aspects of metabolic dysfunction, offering a multifaceted approach to patient care. Its efficacy in promoting weight loss and improving lipid profiles further underscores its relevance in therapeutic strategies aimed at combating obesity-related complications.

Numéro CAS 
97322-87-7
Formule moléculaire
C 24 H 27 NON 5 S
Poids moléculaire 
441.54
Point de fusion 
177 - 184 °C
Informations générales
Numéro CAS 
97322-87-7
Formule moléculaire
C 24 H 27 NON 5 S
Poids moléculaire 
441.54
Point de fusion 
177 - 184 °C
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Troglitazone is widely utilized in research focused on:

  • Diabetes Management: This compound is primarily used in the treatment of type 2 diabetes, helping to improve insulin sensitivity and regulate blood sugar levels, which is crucial for patients managing this condition.
  • Pharmaceutical Research: Researchers explore Troglitazone's mechanisms of action to develop new therapeutic agents. Its unique properties can lead to innovative treatments for metabolic disorders.
  • Cardiovascular Health: Studies indicate that Troglitazone may have beneficial effects on lipid profiles, making it a candidate for research into cardiovascular disease prevention.
  • Anti-inflammatory Applications: The compound is being investigated for its potential anti-inflammatory properties, which could lead to new treatments for conditions characterized by chronic inflammation.
  • Comparative Studies: Troglitazone serves as a benchmark in studies comparing the efficacy and safety of newer antidiabetic medications, providing valuable insights into treatment options.

Citations